Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (31-40 of 610) with videos related to

Pageof 61
Sort By:
The Lancet. Oncology|May 4, 2013
Relapsed childhood acute lymphoblastic leukaemiaDeepa Bhojwani, Ching-Hon Pui
Blood|October 15, 2020
Intensive but tender care for infant ALLHiroto Inaba, Ching-Hon Pui
Oncotarget|November 8, 2017
Minimal residual disease in pediatric ALLChing-Hon Pui, Dario Campana
Nature Reviews. Drug Discovery|February 3, 2007
New therapeutic strategies for the treatment of acute lymphoblastic leukaemiaChing-Hon Pui, Sima Jeha
Leukemia & Lymphoma|September 4, 2008
Intrathecal liposomal cytarabine: more friend than foe?Deepa Bhojwani, Ching-Hon Pui
Clinical Lymphoma|April 4, 2003
Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignanciesRaul C Ribeiro, Ching-Hon Pui
JAMA Oncology|January 7, 2021
The International Collaboration to Save Children With CancerJing-Yan Tang, Ching-Hon Pui
Leukemia & Lymphoma|June 7, 2006
Pitfalls in predicting tumor lysis syndromeScott C Howard, Ching-Hon Pui
The Lancet. Haematology|December 22, 2015
Is another antibody conjugate against ALL needed?Alan S Wayne, Ching-Hon Pui
The New England Journal of Medicine|January 13, 2006
Treatment of acute lymphoblastic leukemiaChing-Hon Pui, William E Evans
Pageof 61

Showing results (31-40 of 610) with videos related to

Sort By:
Pageof 61
The Lancet. Oncology|May 4, 2013
Relapsed childhood acute lymphoblastic leukaemiaDeepa Bhojwani, Ching-Hon Pui
Blood|October 15, 2020
Intensive but tender care for infant ALLHiroto Inaba, Ching-Hon Pui
Oncotarget|November 8, 2017
Minimal residual disease in pediatric ALLChing-Hon Pui, Dario Campana
Nature Reviews. Drug Discovery|February 3, 2007
New therapeutic strategies for the treatment of acute lymphoblastic leukaemiaChing-Hon Pui, Sima Jeha
Leukemia & Lymphoma|September 4, 2008
Intrathecal liposomal cytarabine: more friend than foe?Deepa Bhojwani, Ching-Hon Pui
Clinical Lymphoma|April 4, 2003
Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignanciesRaul C Ribeiro, Ching-Hon Pui
JAMA Oncology|January 7, 2021
The International Collaboration to Save Children With CancerJing-Yan Tang, Ching-Hon Pui
Leukemia & Lymphoma|June 7, 2006
Pitfalls in predicting tumor lysis syndromeScott C Howard, Ching-Hon Pui
The Lancet. Haematology|December 22, 2015
Is another antibody conjugate against ALL needed?Alan S Wayne, Ching-Hon Pui
The New England Journal of Medicine|January 13, 2006
Treatment of acute lymphoblastic leukemiaChing-Hon Pui, William E Evans
Pageof 61